Compounds > mizoribine
Page last updated: 2024-08-26

mizoribine and Recrudescence

mizoribine has been researched along with Recrudescence in 26 studies

Research

Studies (26)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (7.69)18.2507
2000's11 (42.31)29.6817
2010's11 (42.31)24.3611
2020's2 (7.69)2.80

Authors

AuthorsStudies
Endo, S; Fujinaga, S; Hirano, D; Morishita, T; Onuki, Y; Sakuraya, K; Takemasa, Y1
Fujinaga, S; Mizutani, A1
Fujinaga, S; Hirano, D; Mizutani, A; Sakuraya, K; Shimizu, T1
Aoyagi, H; Ariga, T; Hayashi, A; Kobayashi, N; Nakanishi, M; Okamoto, T; Sato, Y; Takahashi, T; Ueno, M; Uetake, K; Yamazaki, T1
Hama, T; Iijima, K; Ishikura, K; Ito, S; Nakamura, H; Nakanishi, K; Nozu, K; Saito-Oba, M; Sako, M; Shima, Y; Yoshikawa, N1
Dang, XQ; Gao, YF; Jiang, XY; Rong, LP; Shen, Q; Xia, ZK; Xu, H; Yi, ZW1
Amano, K; Chino, K; Ito, T; Kato, H; Kondo, T; Kurasawa, T; Nagasawa, H; Nishi, E; Nishimura, K; Ogawa, H; Okuyama, A; Sakai, R; Shibata, A; Takei, H1
Chen, KR; Kamioka, I; Kitagawa, C; Oka, M; Yamada, Y1
Fujimoto, S; Makino, H; Maruyama, S; Matsuo, S; Mori, N; Narita, I; Nishio, S; Okuda, S; Saito, T; Sato, H; Sugiyama, H; Ueda, Y; Yamagata, K; Yokoyama, H; Yuzawa, Y1
Abe, H; Furuno, Y; Kabashima, N; Matsumoto, M; Miyamoto, T; Miyazaki, M; Nakamata, J; Okazaki, M; Otsuji, Y; Serino, R; Shibata, T; Takeuchi, M; Tamura, M; Tokunaga, M1
Arimura, Y; Kawashima, S; Yoshihara, K1
Ando, T; Hattori, S; Honda, M; Ikeda, M; Sasaki, S; Tanaka, Y; Yoshikawa, N1
Kawakami, T; Kimura, K; Shirai, S; Soma, Y1
Fujinaga, S; Hirano, D; Kaneko, K; Nishizaki, N; Ohtomo, Y; Ohtsuka, Y; Shimizu, T; Someya, T1
Fujieda, M; Hayashi, A; Ishihara, M; Morita, T; Ohta, T; Okada, S; Sakano, T; Wakiguchi, H1
Hosoya, M; Isome, M; Kawasaki, Y; Kobayashi, S; Ohara, S; Onishi, N; Suzuki, H; Takahashi, A1
Honda, M; Iijima, I; Ikeda, M; Nakamura, H; Nakanishi, K; Ootomo, Y; Sako, M; Sekine, K; Wada, N; Yoshikawa, N1
Harada, T; Horita, Y; Kohno, S; Miyazaki, M; Nishioka, Y; Suyama, N; Tadokoro, M; Taura, K2
Goto, M; Hamasaki, Y; Hataya, H; Honda, M; Ikeda, M; Ishikura, K1
Igarashi, Y; Inoue, CN; Kondo, Y; Moro, Y1
Konishi, T; Ozawa, K; Saida, K; Saida, T; Zhigang, Z1
Honda, K; Ishikawa, N; Nihei, H; Shimizu, T; Suzuki, K; Tanabe, K; Tokumoto, T; Toma, H; Yagisawa, T1
Ishii, M; Kono, T; Muramatsu, T; Oura, H; Taniguchi, S; Terashima, T1
Aihara, Y; Ibe, M; Imagawa, T; Ito, S; Kobayashi, S; Mitsuda, T; Miyamae, T; Mori, M; Yokota, S1
Honda, M1

Reviews

2 review(s) available for mizoribine and Recrudescence

ArticleYear
[ANCA associated vasculitis and PRGN].
    Nihon Jinzo Gakkai shi, 2009, Volume: 51, Issue:2

    Topics: Animals; Antibodies, Antineutrophil Cytoplasmic; Biomarkers; Cyclophosphamide; Disease Progression; Glomerulonephritis; Glucocorticoids; Humans; Immunosuppressive Agents; Mycophenolic Acid; Recurrence; Ribonucleosides; Vasculitis

2009
Nephrotic syndrome and mizoribine in children.
    Pediatrics international : official journal of the Japan Pediatric Society, 2002, Volume: 44, Issue:2

    Topics: Animals; Child; Female; Humans; Immunosuppressive Agents; Male; Nephrotic Syndrome; Recurrence; Ribonucleosides

2002

Trials

5 trial(s) available for mizoribine and Recrudescence

ArticleYear
Study protocol: high-dose mizoribine with prednisolone therapy in short-term relapsing steroid-sensitive nephrotic syndrome to prevent frequent relapse (JSKDC05 trial).
    BMC nephrology, 2018, 09-10, Volume: 19, Issue:1

    Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Male; Nephrotic Syndrome; Prednisolone; Recurrence; Ribonucleosides; Steroids

2018
Combination therapy with steroids and mizoribine in juvenile SLE: a randomized controlled trial.
    Pediatric nephrology (Berlin, Germany), 2010, Volume: 25, Issue:5

    Topics: Administration, Oral; Adolescent; Adrenal Cortex Hormones; Age of Onset; Child; Disease-Free Survival; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Japan; Kaplan-Meier Estimate; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Methylprednisolone; Prednisolone; Proteinuria; Pulse Therapy, Drug; Recurrence; Ribonucleosides; Time Factors; Treatment Outcome

2010
Effect of single-dose oral mizoribine pulse therapy twice per week for frequently relapsing steroid-dependent nephrotic syndrome.
    Clinical nephrology, 2012, Volume: 78, Issue:1

    Topics: Administration, Oral; Adolescent; Child; Child, Preschool; Cyclosporine; Female; Humans; Immunosuppressive Agents; Infant; Japan; Male; Nephrotic Syndrome; Prednisolone; Pulse Therapy, Drug; Recurrence; Ribonucleosides; Steroids; Time Factors; Treatment Outcome

2012
[Beneficial and adverse effects of high-dosage MZR therapy in the management of children with frequently relapsing nephrotic syndrome].
    Nihon Jinzo Gakkai shi, 2006, Volume: 48, Issue:4

    Topics: Adolescent; Adult; Child; Female; Humans; Immunosuppressive Agents; Male; Nephrotic Syndrome; Prednisolone; Recurrence; Retrospective Studies; Ribonucleosides

2006
Long-term open-trial of mizoribine with prednisolone in 24 patients with multiple sclerosis: safety, clinical and magnetic resonance imaging outcome.
    Internal medicine (Tokyo, Japan), 1999, Volume: 38, Issue:8

    Topics: Adolescent; Adult; Algorithms; Anti-Inflammatory Agents; Child; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Prednisolone; Recurrence; Ribonucleosides

1999

Other Studies

19 other study(ies) available for mizoribine and Recrudescence

ArticleYear
Predictors of Treatment Response and Long-Term Outcomes in Young Children with Steroid-Dependent Nephrotic Syndrome Treated with High-Dose Mizoribine as First-Line Steroid-Sparing Agent.
    The Tohoku journal of experimental medicine, 2022, Volume: 256, Issue:1

    Topics: Child; Child, Preschool; Humans; Immunosuppressive Agents; Nephrotic Syndrome; Recurrence; Retrospective Studies; Ribonucleosides; Steroids

2022
Should rituximab be administered before cyclophosphamide as a first-line steroid-sparing agent to young children with steroid-dependent nephrotic syndrome?
    Clinical and experimental nephrology, 2020, Volume: 24, Issue:12

    Topics: Age Factors; Child; Cyclophosphamide; Drug Administration Schedule; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Kidney; Male; Nephrotic Syndrome; Prednisolone; Recurrence; Remission Induction; Ribonucleosides; Risk Assessment; Risk Factors; Rituximab; Time Factors; Treatment Outcome

2020
Positive effects of single-daily high-dose mizoribine therapy after cyclophosphamide in young children with steroid-dependent nephrotic syndrome.
    Clinical and experimental nephrology, 2019, Volume: 23, Issue:2

    Topics: Adolescent; Age of Onset; Child; Child, Preschool; Cyclophosphamide; Drug Administration Schedule; Female; Humans; Immunosuppressive Agents; Male; Nephrotic Syndrome; Recurrence; Remission Induction; Retrospective Studies; Ribonucleosides; Steroids; Time Factors; Treatment Outcome

2019
Periodically repeated rituximab administrations in children with refractory nephrotic syndrome: 2-year multicenter observational study.
    Pediatric nephrology (Berlin, Germany), 2019, Volume: 34, Issue:1

    Topics: Adolescent; Calcineurin Inhibitors; Child; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Nephrotic Syndrome; Pulse Therapy, Drug; Recurrence; Remission Induction; Ribonucleosides; Rituximab; Treatment Outcome

2019
Usefulness of mizoribine administration in children with frequently relapsing nephrotic syndrome, and the relationship between pharmacokinetic parameters and efficacy: a multicenter prospective cohort study in China.
    World journal of pediatrics : WJP, 2019, Volume: 15, Issue:3

    Topics: Adolescent; Child; Child, Preschool; China; Female; Humans; Immunosuppressive Agents; Male; Nephrotic Syndrome; Prospective Studies; Recurrence; Ribonucleosides

2019
Successful treatment of class IV+V lupus nephritis with combination therapy of high-dose corticosteroids, tacrolimus and intravenous cyclophosphamide.
    Internal medicine (Tokyo, Japan), 2013, Volume: 52, Issue:10

    Topics: Adolescent; Antihypertensive Agents; Biphenyl Compounds; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Female; Humans; Hypertension, Renal; Immunosuppressive Agents; Infusions, Intravenous; Irbesartan; Lupus Erythematosus, Systemic; Lupus Nephritis; Nephrotic Syndrome; Prednisolone; Pulse Therapy, Drug; Recurrence; Ribonucleosides; Severity of Illness Index; Tacrolimus; Tetrazoles

2013
A case of microscopic polyangiitis with skin manifestations in a seven-year-old girl.
    Dermatology online journal, 2013, Sep-14, Volume: 19, Issue:9

    Topics: Antibodies, Antineutrophil Cytoplasmic; Autoantigens; Child; Female; Hemorrhage; Humans; Immunosuppressive Agents; Lung; Lung Diseases; Microscopic Polyangiitis; Peroxidase; Prednisolone; Recurrence; Ribonucleosides; Skin; Tomography, X-Ray Computed; Vasculitis, Leukocytoclastic, Cutaneous

2013
Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR).
    Clinical and experimental nephrology, 2015, Volume: 19, Issue:3

    Topics: Aged; Aged, 80 and over; Biopsy; Creatinine; Cyclophosphamide; Cyclosporine; Female; Follow-Up Studies; Glomerulonephritis; Glomerulonephritis, Membranoproliferative; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Humans; Immunosuppressive Agents; Japan; Kidney; Male; Methylprednisolone; Mycophenolic Acid; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisolone; Proteinuria; Recurrence; Registries; Retrospective Studies; Ribonucleosides; Treatment Outcome

2015
Mizoribine for relapsed proteinuria in an adult IgA nephropathy patient.
    Clinical nephrology, 2008, Volume: 70, Issue:5

    Topics: Dose-Response Relationship, Drug; Glomerulonephritis, IGA; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Male; Middle Aged; Proteinuria; Recurrence; Ribonucleosides

2008
Successful use of mizoribine to treat recurrent corticosteroid-resistant palpable purpura in a patient with henoch-schonlein purpura nephritis.
    Archives of dermatology, 2010, Volume: 146, Issue:2

    Topics: Drug Resistance; Humans; IgA Vasculitis; Immunosuppressive Agents; Male; Middle Aged; Nephritis; Recurrence; Ribonucleosides; Vasculitis, Leukocytoclastic, Cutaneous

2010
Single daily high-dose mizoribine therapy for children with steroid-dependent nephrotic syndrome prior to cyclosporine administration.
    Pediatric nephrology (Berlin, Germany), 2011, Volume: 26, Issue:3

    Topics: Child; Child, Preschool; Cyclosporine; Drug Administration Schedule; Female; Humans; Immunosuppressive Agents; Infant; Japan; Male; Nephrotic Syndrome; Recurrence; Ribonucleosides; Steroids; Time Factors; Treatment Outcome

2011
Oral mizoribine pulse therapy for patients with steroid-resistant and frequently relapsing steroid-dependent nephrotic syndrome.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2005, Volume: 20, Issue:10

    Topics: Administration, Oral; Anti-Inflammatory Agents; Child; Child, Preschool; Cyclosporine; Drug Resistance; Female; Humans; Immunosuppressive Agents; Male; Nephrotic Syndrome; Prednisolone; Recurrence; Ribonucleosides

2005
[Treatment guidelines for the idiopathic nephrotic syndrome in children].
    Nihon Jinzo Gakkai shi, 2005, Volume: 47, Issue:7

    Topics: Child; Clinical Trials as Topic; Cyclophosphamide; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Immunosuppressive Agents; Methylprednisolone; Nephrotic Syndrome; Prednisolone; Pulse Therapy, Drug; Recurrence; Ribonucleosides

2005
Mizoribine induces remission of relapsed ANCA-associated renal vasculitis.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2006, Volume: 21, Issue:4

    Topics: Aged; Antibodies, Antineutrophil Cytoplasmic; Female; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Kidney Diseases; Recurrence; Remission Induction; Ribonucleosides; Vasculitis

2006
Changing mizoribine administration from three divided doses to one single dose induced remission of relapsed membranous nephropathy.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2006, Volume: 21, Issue:8

    Topics: Aged; Drug Administration Schedule; Drug Therapy, Combination; Female; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Prednisolone; Proteinuria; Recurrence; Remission Induction; Ribonucleosides

2006
Steroid-sparing effect of mizoribine in long-term nephrotic syndrome of children.
    Pediatric nephrology (Berlin, Germany), 1994, Volume: 8, Issue:3

    Topics: Child; Child, Preschool; Combined Modality Therapy; Humans; Immunosuppressive Agents; Nephrotic Syndrome; Prednisolone; Proteinuria; Recurrence; Ribonucleosides

1994
Effect of tacrolimus in renal transplant recipients with immunoglobulin-A nephropathy.
    Transplantation proceedings, 2000, Volume: 32, Issue:7

    Topics: Adult; Azathioprine; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerulonephritis, IGA; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Recurrence; Retrospective Studies; Ribonucleosides; Survival Rate; Tacrolimus; Time Factors

2000
Recalcitrant subcorneal pustular dermatosis and bullous pemphigoid treated with mizoribine, an immunosuppressive, purine biosynthesis inhibitor.
    The British journal of dermatology, 2000, Volume: 143, Issue:6

    Topics: Adult; Chronic Disease; Female; Humans; Immunosuppressive Agents; Pemphigoid, Bullous; Recurrence; Ribonucleosides; Skin Diseases, Vesiculobullous

2000
Mizoribine as an effective combined maintenance therapy with prednisolone in child-onset systemic lupus erythematosus.
    Pediatrics international : official journal of the Japan Pediatric Society, 2002, Volume: 44, Issue:2

    Topics: Adolescent; Anti-Inflammatory Agents; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Plasmapheresis; Prednisolone; Recurrence; Ribonucleosides

2002